| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |